Gene set enrichment and pathway analysis data both demonstrated that the ubiquitin proteasome pathway via UCHL1 and CCND2-dependent cell cycle control pathways are copersistent and differentially expressed in t(4;14) high cytogenetic risk MM compared to the other non-t(4;14) MM group. This evidence concerns the gene CCND2 and Miyoshi myopathy.